Identification of novel targets for immunotherapies in subsets of patients with diffuse large B-cell lymphoma (DLBCL)

Alexander D. Heini,Ulrike Bacher,Thomas Pabst

BRITISH JOURNAL OF HAEMATOLOGY（2024）

引用 0|浏览2

暂无评分

摘要

Personalized treatment options for subsets of patients with DLBCL are beginning to emerge. Caracciolo et al. explore UMG1, an epitope of CD43 as a potential target for certain patients with DLBCL, and demonstrate promising preclinical activity of an Anti-UMG1-antibody.

查看译文

关键词

bispecific T-cell engager,DLBCL,personalized medicine,UMG1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要